Caladrius Biosciences Inc... (CLBS)

NASDAQ: CLBS · Real-Time Price · USD

0.43

-0.08 (-16.05%)

At close: Sep 15, 2022, 4:00 AM

Caladrius Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	33.35M	12.75M	94.97M	12.77M	12.94M	28.74M	16.51M	21.16M	26.68M	20.75M	14.03M	12.67M	11.75M	14.42M	10.3M	14.37M	22.73M	21.6M	29.16M	15.08M	23.04M	12M	14.71M	18.61M	17.7M	25.43M
Short-Term Investments	39.64M	75.77M	151K	87.38M	93.16M	82.77M	18.06M	19.11M	8.21M	n/a	11.13M	16.49M	21.9M	23.95M	32.75M	31.78M	27.6M	26.98M	25.92M	44.37M	36.32M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	10M	n/a	n/a	n/a	n/a	n/a	18.06M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.12B	n/a	-1.08B	-1.03B	-986.04M
Other Long-Term Assets	648K	708K	764K	361K	42K	41K	-17.45M	41K	772K	847K	1.08M	1.31M	1.4M	1.49M	309K	418.15K	442.81K	1.43M	1.43M	1.42M	1.4M	655.48K	713.45K	726.77K	812.87K	894.5K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	144.26K	234.46K	401.56K	335.65K	3.17M	2.89M	4.27M	2.89M	2.61M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.96M	2.18M	-151K	1.96M	1.99M	2.52M	758K	989K	1.74M	461K	815K	1.08M	1.16M	1.28M	1.05M	1.1M	1.23M	5.8M	5.8M	5.92M	10.71M	6.77M	7.05M	7.08M	8.66M	7.58M
Total Current Assets	74.95M	90.7M	94.97M	102.11M	108.08M	114.03M	35.33M	41.26M	36.63M	21.21M	25.97M	30.24M	34.82M	39.65M	44.11M	47.25M	51.55M	54.53M	61.11M	65.77M	70.41M	21.93M	24.65M	29.96M	29.25M	35.62M
Property-Plant & Equipment	282K	55K	62K	70K	492K	533K	57K	720K	83K	87K	100K	115K	130K	148K	165K	182.6K	98.12K	178.11K	256.9K	364.12K	432.85K	16.76M	17.15M	17.12M	17.04M	16.92M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.18M	9.32M	9.46M	9.61M	9.75M
Total Long-Term Assets	10.93M	763K	826K	431K	534K	574K	671K	761K	855K	934K	1.18M	1.43M	1.53M	1.64M	474K	600.75K	540.93K	2.19M	2.27M	1.78M	1.84M	26.59M	27.18M	27.31M	27.46M	27.57M
Total Assets	85.88M	91.46M	97.01M	102.54M	108.61M	114.61M	36M	42.02M	37.48M	22.14M	27.15M	31.67M	36.35M	41.29M	44.58M	47.85M	52.09M	56.72M	63.38M	67.56M	72.25M	48.53M	51.83M	57.28M	56.71M	63.18M
Account Payables	1.1M	697K	1.93M	768K	1.24M	2.31M	1.02M	1.1M	592K	64K	1.49M	844K	559K	553K	762K	447.22K	505.67K	866.84K	1.34M	879.63K	1.11M	3.58M	4.37M	3.25M	2.9M	3.98M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10.36M	5.1M	5.87M	7.23M	5.64M
Short-Term Debt	178K	205K	n/a	297K	366K	381K	370K	359K	349K	339K	354K	368K	382K	396K	n/a	n/a	23.29K	92.05K	159.18K	359.55K	1.03M	4.21M	3.97M	3.07M	6.02M	2.52M
Other Current Liabilities	2.08M	1.9M	2.59M	3.01M	2.25M	1.74M	2.12M	2.72M	2.54M	4.22M	4.13M	4.77M	4.77M	4.15M	4.86M	4.44M	5.3M	7M	7.81M	10.14M	12.41M	5.06M	6.06M	6.37M	6.2M	6.32M
Total Current Liabilities	3.36M	2.8M	4.52M	4.07M	3.86M	4.44M	3.51M	4.18M	3.48M	4.62M	5.98M	5.98M	5.71M	5.1M	5.62M	4.89M	5.83M	7.96M	9.31M	11.37M	14.55M	23.21M	19.5M	18.55M	22.36M	18.46M
Long-Term Debt	383K	421K	n/a	53K	79K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	23.29K	1.92M	2.82M	3.56M	3.96M	7.94M
Other Long-Term Liabilities	n/a	n/a	485K	n/a	n/a	155K	254K	351K	445K	536K	624K	710K	1.02M	1.73M	1.51M	2.15M	2.8M	3.44M	3.87M	3.2M	3.64M	19.81M	19.79M	19.77M	19.91M	19.83M
Total Long-Term Liabilities	383K	421K	485K	53K	79K	155K	254K	351K	445K	536K	624K	710K	1.02M	1.73M	1.51M	2.15M	2.8M	3.44M	3.87M	3.2M	3.66M	27.29M	28.27M	28.74M	28.72M	31.54M
Total Liabilities	3.74M	3.22M	5.01M	4.13M	3.94M	4.59M	3.76M	4.53M	3.92M	5.16M	6.6M	6.69M	6.73M	6.83M	7.13M	7.04M	8.63M	11.4M	13.19M	14.57M	18.21M	50.5M	47.77M	47.29M	51.08M	50M
Total Debt	561K	626K	n/a	350K	445K	536K	624K	710K	794K	339K	354K	368K	382K	396K	n/a	n/a	23.29K	92.05K	159.18K	359.55K	1.05M	6.12M	6.79M	6.62M	9.99M	10.46M
Common Stock	61K	61K	60K	60K	60K	60K	19K	19K	16K	11K	11K	10K	10K	10K	10K	9.85K	9.73K	9.57K	9.48K	9.43K	8.91K	8.95K	8.21K	8.18K	5.93K	59.12K
Retained Earnings	-463.87M	-457.24M	-453.02M	-446.22M	-439.3M	-433.61M	-425.55M	-420.12M	-414.79M	-421.39M	-417.4M	-412.44M	-407.55M	-402.41M	-397.98M	-394.42M	-390.87M	-386.79M	-381.81M	-378.95M	-375.43M	-414.15M	-404.79M	-398.83M	-391.95M	-384.11M
Comprehensive Income	-70K	-196K	-70K	-64K	-17K	-72K	-13K	-12K	-7K	n/a	2K	2K	n/a	-18K	-32K	-28.62K	-31.09K	-58.72K	-27.98K	-28.72K	-57.86K	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	82.39M	88.5M	92M	98.67M	104.93M	110.27M	32.5M	37.74M	33.81M	17.24M	20.82M	25.25M	29.89M	34.73M	37.73M	41.08M	43.74M	45.59M	50.51M	53.33M	54.42M	-790.97K	4.88M	10.75M	6.05M	13.66M
Total Investments	49.64M	75.77M	151K	87.38M	93.16M	82.77M	36.12M	19.11M	8.21M	n/a	11.13M	16.49M	21.9M	23.95M	32.75M	31.78M	27.6M	26.98M	25.92M	44.37M	36.32M	-1.12B	n/a	-1.08B	-1.03B	-986.04M

Advertisement

Caladrius Biosciences Inc... (CLBS)

Caladrius Biosciences Balance Sheet Statement